The authors concluded that by exploiting this trafficking and release mechanism, they were able to achieve significant tumor response rates in B16 melanoma mouse models and noted a significant activation of DCs and infiltration of CD8+ T cells, mediating a strong antitumor response. The gene discussed is CD8A; the disease is neoplasm.